Exosomes and Conventional Outflow Homeostasis
外泌体和常规流出稳态
基本信息
- 批准号:10737784
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AnteriorAqueous HumorAreaBindingBiologyCellsCellular biologyCorneaCytoskeletonDataDiseaseElementsEnvironmentEquilibriumExperimental DesignsExposure toExtracellular MatrixExtracellular Matrix ProteinsEyeFeedbackFibroblastsFibronectinsFibrosisFlow CytometryFunctional disorderGene ExpressionGenesGlaucomaHomeostasisHumanImmunofluorescence ImmunologicIn SituIn VitroIntegrinsInterruptionLabelMaintenanceMalignant NeoplasmsMatrix MetalloproteinasesMechanicsMediatingMentorsMethodsMicroRNAsMonitorOcular HypertensionOrgan Culture TechniquesOutcomes ResearchPathway interactionsPatternPerfusionPhasePhenotypePhysiologic Intraocular PressureProcessProductionProteomicsRegulationRejuvenationResearchResistanceRho-associated kinaseRisk FactorsRoleStretchingTechniquesTherapeuticTissuesTrabecular meshwork structureTracerTrainingWaste Managementcell typedesigndifferential expressionex vivo perfusionexosomeextracellularextracellular vesiclesintercellular communicationkinase inhibitornanosizednanovesiclenatural flownoveloptic nerve disorderrepairedskillstheories
项目摘要
Project Summary
Glaucoma is an optic neuropathy in which the primary risk factor is elevated intraocular pressure (IOP).
Dysregulation of conventional outflow homeostasis results in elevated IOP. Key elements of outflow homeostasis
are the turnover of extracellular matrix (ECM), which also determines preferential flow passageways through the
tissue. In fact, there is recent evidence of differential ECM gene expression between regions of low and high
flow in the trabecular meshvvork (TM). In cancer, dysregulation of ECM homeostasis has been demonstrated to
involve extracellular nanovesicles, known as exosomes. Exosome release is tightly regulated, and they are
differentiated from other nanovesicles based on their size, cell type-specific function and cargo. Amongst others,
their functions include waste management, cell-cell signaling and ECM turnover. As a result, we hypothesize
that exosomes released from TM cells play a role in opsonizing ECM in the outflow pathway, contributing
to segmental flow, and altered ECM homeostasis in glaucoma. This study aims to investigate the role of
exosomes in regulating ECM by human TM cells and in TM tissues. During the independent phase, I will examine
how IOP effects exosome release and regulation in the conventional outflow pathway in terms of segmental flow.
Next, using human TM cells and TM tissues, I will investigate how exosomes can be used to ameliorate a
glaucoma phenotype and ocular hypertension. As outcomes of this research we expect to (i) identify a role for
exosomes in segmental flow (ii) determine the effect of IOP on exosome release and function (iii) identify ECM
targets for exosome regulation and, (iv) ascertain if exosomes can be used to normalize ECM homeostasis.
项目摘要
青光眼是一种以眼压升高为主要危险因素的视神经病变。
传统的流出平衡失调会导致眼压升高。外流动态平衡的关键因素
是细胞外基质(ECM)的周转,这也决定了优先通过
组织。事实上,最近有证据表明,ecm基因在低表达区域和高表达区域之间存在差异。
小梁内的流动(TM)。在癌症中,ECM动态平衡的失调已被证明
包括细胞外纳米囊泡,也就是外体。外切体的释放受到严格的监管,而且它们
根据其大小、特定细胞类型的功能和载物区别于其他纳米囊泡。其中,
它们的功能包括废物管理、细胞-细胞信号和ECM周转。因此,我们假设
TM细胞释放的外切体在细胞外流途径中发挥调理ECM的作用,
导致节段性血流,改变了青光眼的细胞外基质稳态。本研究的目的是探讨在人类免疫系统中
Exosome在调节人TM细胞和TM组织细胞外基质中的作用在独立阶段,我将审查
根据节段性血流,眼压如何影响传统流出途径中的外体释放和调节。
接下来,使用人类TM细胞和TM组织,我将研究如何使用外切体来改善
青光眼表型和高眼压。作为本次研究的结果,我们希望(I)确定以下角色
节段性血流中的外切体(II)确定眼压对外切体释放和功能的影响(III)识别细胞外基质
外切体调节的靶点,以及(Iv)确定外切体是否可用于使ECM动态平衡正常化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fiona McDonnell其他文献
Fiona McDonnell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fiona McDonnell', 18)}}的其他基金
相似海外基金
The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
- 批准号:
10667863 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
- 批准号:
10718932 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Regulation of aqueous humor flow by exosomal miRNA
外泌体 miRNA 对房水流动的调节
- 批准号:
23K09011 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
- 批准号:
23H03063 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma
用工程纳米颗粒调节房水流出以治疗青光眼
- 批准号:
10649763 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
- 批准号:
10510279 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
- 批准号:
10682543 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
- 批准号:
10155489 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
ocular tissue response by intraocular pressure and aqueous humor in glaucoma - investigation for the mechanism and biomarkers of intraocular pressure regulation
青光眼中眼压和房水引起的眼组织反应——眼压调节机制和生物标志物的研究
- 批准号:
20H03839 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
- 批准号:
10405079 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别: